This invention provides methods for treatment and inhibition of a male
subject having an Androgen Decline in Aging Male (ADAM)-associated
condition, for example sexual dysfunction, decreased sexual libido,
erectile dysfunction, hypogonadism, sarcopenia, osteopenia, osteoporosis,
an alteration in cognition and mood, depression, anemia, hair loss,
obesity, muscle loss, dry eye, memory loss, benign prostate hyperplasia
and/or prostate cancer, by administering to the subject a selective
androgen receptor modulator (SARM) compound and/or its analog,
derivative, isomer, metabolite, pharmaceutically acceptable salt,
pharmaceutical product, hydrate, N-oxide, pro-drug, polymorph, crystal,
or any combination thereof.